.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Moodys
Queensland Health
Novartis
US Army
Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Teva
Farmers Insurance

Generated: January 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: disopyramide phosphate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDAG.D. Searle LLC Division of Pfizer Inc0025-2732-31100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2732-31)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDAG.D. Searle LLC Division of Pfizer Inc0025-2732-34100 CAPSULE, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0025-2732-34)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDAG.D. Searle LLC Division of Pfizer Inc0025-2732-51500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2732-51)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDAG.D. Searle LLC Division of Pfizer Inc0025-2742-34100 CAPSULE, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0025-2742-34)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDAG.D. Searle LLC Division of Pfizer Inc0025-2742-31100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2742-31)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDAG.D. Searle LLC Division of Pfizer Inc0025-2742-51500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2742-51)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDACarilion Materials Management68151-0526-31 CAPSULE, GELATIN COATED in 1 PACKAGE (68151-0526-3)
Gd Searle LlcNORPACE CRdisopyramide phosphateCAPSULE, EXTENDED RELEASE;ORAL018655NDACarilion Materials Management68151-0527-31 CAPSULE, GELATIN COATED in 1 PACKAGE (68151-0527-3)
Mayne PharmaDISOPYRAMIDE PHOSPHATEdisopyramide phosphateCAPSULE;ORAL070173ANDAActavis Pharma, Inc.0591-5560-01100 CAPSULE in 1 BOTTLE, PLASTIC (0591-5560-01)
Mayne PharmaDISOPYRAMIDE PHOSPHATEdisopyramide phosphateCAPSULE;ORAL070173ANDAMayne Pharma Inc.51862-093-01100 CAPSULE in 1 BOTTLE, PLASTIC (51862-093-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cipla
Merck
US Army
Mallinckrodt
Fuji
Dow
Healthtrust
Teva
Daiichi Sankyo

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot